Skip to main content

Table 1 Multivariate analysis (BBCC validation TMA) of recurrence-free survival, adjusted for pT, pN, Grading, ER, PR, HER2 and SERBP1

From: Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis

Characteristic N Adjusted Hazard Ratio 95% CI p-value
pTa 1 312 1     
  2 227 1.85 1.10 to 3.10 0.02
  3 29 3.48 1.64 to 7.37 0.001
  4 37 7.25 3.81 to 13.80 1.7E-09
pNa 0 351 1     
  1 254 2.41 1.47 to 3.94 0.0005
Grading 1 49 1     
  2 361 1.40 0.43 to 4.57 0.57
  3 195 1.95 0.57 to 6.64 0.29
ER Neg 143 1     
  Pos 462 1.19 0.63 to 2.24 0.59
PR Neg 205 1     
  pos 400 0.58 0.33 to 1.04 0.067
HER2 Neg 511 1     
  pos 94 1.06 0.60 to 1.85 0.85
SERBP1 IRS 0-2 91 1     
  IRS 3-12 514 0.59 0.35 to 0.98 0.039
  1. aAccording to Sobin LH, Wittekind CH: UICC: TNM Classification of Malignant Tumours. 6th edition, New York: Wiley; 2002 [27].
  2. pT: Pathological assessment of the primary tumour.
  3. pN: Pathological assessment of the regional lymph nodes.
  4. CI: Confidence interval.